Cargando…
A case of anti-HMGCR myopathy in a patient with breast cancer and anti-Th/To antibodies
Statins competitively inhibit the activity of HMGCR (3-hydroxy-3-methylglutaryl coenzyme A reductase), which is a key enzyme in cholesterol synthesis. These are effective drugs for the management of cardiovascular disease and are generally well tolerated but several side effects have been reported....
Autores principales: | Chérif, Mohammad Yassine, Raftakis, Ioannis, Weynand, Marjolaine, Dragan, Elena, Nagant, Carole, Lecomte, Sophie, Badot, Valérie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530299/ https://www.ncbi.nlm.nih.gov/pubmed/37771688 http://dx.doi.org/10.1093/omcr/omad097 |
Ejemplares similares
-
A case of left foot drop as initial symptom of granulomatosis with polyangiitis: Triggered by COVID‐19 disease?
por: Weynand, Marjolaine, et al.
Publicado: (2022) -
Anti-HMGCR Myopathy
por: Mohassel, Payam, et al.
Publicado: (2018) -
Myopathy with anti-HMGCR antibodies: Perimysium and myofiber pathology
por: Alshehri, Ali, et al.
Publicado: (2015) -
Lower limb ulcer and Raynaud's phenomenon
por: Chérif, Mohammad Yassine, et al.
Publicado: (2022) -
Clinical course and treatment of anti-HMGCR antibody–associated necrotizing autoimmune myopathy
por: Ramanathan, Sudarshini, et al.
Publicado: (2015)